Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Trial of TRC101 in CKD Patients With Metabolic Acidosis
2016-003825-41Phase 3Completed
- Sponsor
- Tricida, Inc.
- Start
- Jul 2017
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in metabolic acidosis comparing TRC101 with Placebo (2 arms). Started Jul 2017; status: completed.
02
Drugs
veverimer
03
Conditions
metabolic acidosis
Beyond the preview
Go deeper on 2016-003825-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003825-41.